667 related articles for article (PubMed ID: 29247858)
21. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
23. Repurposing of 5-nitrofuran-3,5-disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents.
Carvalho DB; das Neves AR; Portapilla GB; Soares O; Santos LBB; Oliveira JRS; Vianna LS; Judice WAS; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; de Albuquerque S; Baroni ACM
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200472. PubMed ID: 36534890
[TBL] [Abstract][Full Text] [Related]
24. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
25. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
[TBL] [Abstract][Full Text] [Related]
26. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents.
Filardi LS; Brener Z
Mem Inst Oswaldo Cruz; 1984; 79(2):221-5. PubMed ID: 6443014
[TBL] [Abstract][Full Text] [Related]
27. 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene.
Gerpe A; Alvarez G; Benítez D; Boiani L; Quiroga M; Hernández P; Sortino M; Zacchino S; González M; Cerecetto H
Bioorg Med Chem; 2009 Nov; 17(21):7500-9. PubMed ID: 19811923
[TBL] [Abstract][Full Text] [Related]
28. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi.
Cassiano Martinho AC; de Melo Resende D; Landin ES; Dit Lapierre TJWJ; Bernardes TCD; Martins LC; Ferreira RS; Murta SMF; de Oliveira Rezende Júnior C
ChemMedChem; 2022 Oct; 17(19):e202200211. PubMed ID: 35993440
[TBL] [Abstract][Full Text] [Related]
30. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-Trypanosoma cruzi activity of diaryldiazepines.
Menezes JC; Vaz LB; de Abreu Vieira PM; da Silva Fonseca K; Carneiro CM; Taylor JG
Molecules; 2014 Dec; 20(1):43-51. PubMed ID: 25546620
[TBL] [Abstract][Full Text] [Related]
32. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi.
Elhalem E; Bailey BN; Docampo R; Ujváry I; Szajnman SH; Rodriguez JB
J Med Chem; 2002 Aug; 45(18):3984-99. PubMed ID: 12190320
[TBL] [Abstract][Full Text] [Related]
34. Phenothiazinium Dyes Are Active against
Bulhões Portapilla G; Pereira LM; Bronzon da Costa CM; Voltarelli Providello M; Sampaio Oliveira PA; Goulart A; Ferreira Anchieta N; Wainwright M; Leite Braga GÚ; de Albuquerque S
Biomed Res Int; 2019; 2019():8301569. PubMed ID: 31355283
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
36. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy of Chagas disease.
Urbina JA
Curr Pharm Des; 2002; 8(4):287-95. PubMed ID: 11860367
[TBL] [Abstract][Full Text] [Related]
38. In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, México.
Domínguez-Díaz LR; Eugenia Ochoa M; Soto-Castro D; Farfán N; Morales-Chamorro M; Yépez-Mulia L; Pérez-Campos E; Santillan R; Moreno-Rodríguez A
Bioorg Med Chem; 2021 Oct; 48():116417. PubMed ID: 34571489
[TBL] [Abstract][Full Text] [Related]
39. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
[TBL] [Abstract][Full Text] [Related]
40. Identification of Novel Functionalized Carbohydrazonamides Designed as Chagas Disease Drug Candidates.
do Nascimento MSS; Câmara VRF; da Costa JS; Barbosa JMC; Lins ASM; Salomão K; de Castro SL; Carvalho SA; da Silva EF; Fraga CAM
Med Chem; 2020; 16(6):774-783. PubMed ID: 31244442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
